EFFECT ON ENALAPRIL (MK-421) AND METOPROLOL (MTP) ON BLOOD-PRESSURE, CONVERTING ENZYME, RENIN, AND CATECHOLAMINES

被引：0
|
作者：
WINER, N [1 ]
CARTER, CH [1 ]
机构：
[1] UNIV MISSOURI,SCH MED,KANSAS CITY,MO 64108
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1983年 / 33卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：232 / 232
页数：1
相关论文
共 50 条
  • [21] BLOOD-PRESSURE CONTROL AND HYPERTENSIVE HEART CHANGES IN THE DAHL (D) RAT - MK-421 (AN ANGIOTENSIN-I CONVERTING ENZYME-INHIBITOR, CEI) VERSUS HYDROCHLOROTHIAZIDE (HTZ)
    SHARMA, JN
    FERNANDEZ, PG
    KIM, BK
    TRIGGLE, CR
    IDIKIO, H
    LAHER, I
    CLINICAL RESEARCH, 1983, 31 (02): : A335 - A335
  • [22] LEFT-VENTRICULAR REGRESSION AND BLOOD-PRESSURE CONTROL IN THE DAHL (D) RAT WITH MK-421 (AN ANGIOTENSIN-I CONVERTING ENZYME-INHIBITOR, CEI) AND HYDROCHLOROTHIAZIDE (HTZ)
    FERNANDEZ, PG
    SHARMA, JN
    KIM, BK
    TRIGGLE, CR
    IDIKIO, H
    LAHER, I
    CLINICAL RESEARCH, 1983, 31 (02): : A332 - A332
  • [23] EFFECTS OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK-421 IN HUMAN HYPERTENSION
    GAVRAS, H
    BIOLLAZ, J
    WAEBER, B
    BRUNNER, HR
    GAVRAS, I
    DAVIES, RO
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 1982, 4 (1-2) : 303 - 314
  • [24] ACUTE AND LONG-TERM EFFECTS OF THE NEW CONVERTING ENZYME-INHIBITOR MK 421 ON BLOOD-PRESSURE AND THE RENIN-ANGIOTENSIN SYSTEM IN HYPERTENSIVE PATIENTS
    KOLLOCH, R
    STUMPE, KO
    BAHNER, U
    KRUCK, F
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1982, 12 (02) : 20 - 20
  • [25] ENALAPRIL(MK-421), AN ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR - EFFECTS ON SYMPATHETIC NERVOUS-SYSTEM (SNS) FUNCTION DURING TREATMENT OF HYPERTENSION
    BERNSTEIN, KN
    MOSLEY, C
    OCONNOR, DT
    CERVENKA, J
    CLINICAL RESEARCH, 1983, 31 (02): : A246 - A246
  • [26] MK-421 - A NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR FOR ESSENTIAL-HYPERTENSION
    FERGUSON, RK
    VLASSES, PH
    SWANSON, BN
    COOPER, DJ
    DAVIES, RO
    ABRAMS, WB
    AMERICAN JOURNAL OF CARDIOLOGY, 1981, 47 (02): : 470 - 470
  • [27] EFFECTS OF THE ORAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR MK-421 IN HUMAN HYPERTENSION
    GAVRAS, H
    BIOLLAZ, J
    WAEBER, B
    BRUNNER, HR
    GAVRAS, I
    SACKEL, H
    CHAROCOPOS, F
    DAVIES, RO
    CLINICAL SCIENCE, 1981, 61 : S281 - S283
  • [28] INDUCTION OF ANGIOTENSIN-CONVERTING ENZYME WITH THE ACE INHIBITORY COMPOUND MK-421 IN RAT LUNG
    FORSLUND, T
    FYHRQUIST, F
    GRONHAGENRISKA, C
    TIKKANEN, I
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 80 (01) : 121 - 125
  • [29] EFFECTS IN HEALTHY-SUBJECTS OF A NEW NON-THIOL-CONTAINING ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, ENALAPRIL MALEATE (MK-421)
    NAKASHIMA, M
    NISHIJIMA, K
    CLINICAL SCIENCE, 1982, 63 : S183 - S185
  • [30] EFFECT OF THE CONVERTING ENZYME-INHIBITOR (CEI) MK-421 ON ISCHEMIC ACUTE-RENAL-FAILURE (ARF) IN THE RAT
    KOELZ, AM
    BRUNNER, FP
    WUNDERLICH, P
    THIEL, GT
    KIDNEY INTERNATIONAL, 1983, 23 (06) : 902 - 902
12345